Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5177006
Max Phase: Preclinical
Molecular Formula: C38H59N11O10
Molecular Weight: 829.96
Associated Items:
ID: ALA5177006
Max Phase: Preclinical
Molecular Formula: C38H59N11O10
Molecular Weight: 829.96
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)O)C(C)C)[C@@H](C)O)C(C)C
Standard InChI: InChI=1S/C38H59N11O10/c1-18(2)29(35(56)49-31(20(5)50)36(57)46-25(12-9-15-42-38(40)41)32(53)48-30(19(3)4)37(58)59)47-33(54)26(13-14-28(39)52)45-34(55)27(44-21(6)51)16-22-17-43-24-11-8-7-10-23(22)24/h7-8,10-11,17-20,25-27,29-31,43,50H,9,12-16H2,1-6H3,(H2,39,52)(H,44,51)(H,45,55)(H,46,57)(H,47,54)(H,48,53)(H,49,56)(H,58,59)(H4,40,41,42)/t20-,25+,26+,27+,29+,30+,31+/m1/s1
Standard InChI Key: WSRPKCPSNWDWPM-WNYXTRFZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 829.96 | Molecular Weight (Monoisotopic): 829.4446 | AlogP: -2.05 | #Rotatable Bonds: 24 |
Polar Surface Area: 352.91 | Molecular Species: ZWITTERION | HBA: 10 | HBD: 13 |
#RO5 Violations: 2 | HBA (Lipinski): 21 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.78 | CX Basic pKa: 25.73 | CX LogP: -4.26 | CX LogD: -4.26 |
Aromatic Rings: 2 | Heavy Atoms: 59 | QED Weighted: 0.03 | Np Likeness Score: 0.16 |
1. Brusa I, Sondo E, Falchi F, Pedemonte N, Roberti M, Cavalli A.. (2022) Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives., 65 (7.0): [PMID:35377645] [10.1021/acs.jmedchem.1c01897] |
Source(1):